4074 The Role of Immortal Time Bias When Linking Treatment to Outcomes among Older Patients with Incident Hodgkin Lymphoma (HL) using Surveillance, Epidemiology and End Results (SEER)-Medicare Data

OBJECTIVES/GOALS: Older patients with HL have worse outcomes than younger patients, which may reflect treatment selection, including fewer chemotherapy cycles. Immortal time bias exists when patients must survival to initiation, and even completion, of treatment. We described treatment length and de...

ver descrição completa

Detalhes bibliográficos
Principais autores: Angie Mae Rodday, Theresa Hahn, Peter K Lindenauer, Susan K Parsons
Formato: Artigo
Idioma:English
Publicado em: Cambridge University Press 2020-06-01
coleção:Journal of Clinical and Translational Science
Acesso em linha:https://www.cambridge.org/core/product/identifier/S205986612000151X/type/journal_article